Table 4.

Clinical observations of Chinese herbal medicine combined with decitabine in the treatment of high-risk MDS

Group	Complete remission	Mitigation	Hematologic improvement	Stable condition	Disease progression	Efficacy
Traditional Chinese medicine group (16 people)	18.75% (3/16)	18.75% (3/16)	18.75% (3/16)	6.25% (1/16)	3.75% (6/16)	56.25% (9/16)
Western medicine group (14 people)	25.00% (3/14)	25.00% (2/14)	41.67% (3/14)	0.00% (0/14)	8.33% (6/14)	57.14% (8/14)

Abbreviation: MDS, myelodysplastic syndrome.